During the past decade, Ocular Technology Group - international conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocular Technology Group - international" #1 collaborator was "Allergan" with 1 trials as a collaborator and "Optometric Technology Group Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ocular Technology Group - international" are "Dry Eye" (2 trials), "Dry Eye Syndrome" (1 trials), "Dry Eye Syndromes" (1 trials), "Refractive Error" (1 trials) and "Vision Correction" (1 trials). Many other conditions were trialed in "Ocular Technology Group - international" in a lesser frequency.

Most popular intervention types in "Ocular Technology Group - international" are "Device" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboxymethylcellulose sodium, glycerin and polysorbate 80" (1 trials), "Hioxifilcon A Test" (1 trials), "Hioxifilcon A With Cosmetic Ring Control" (1 trials), "Multifocal Test Contact lens" (1 trials) and "OPTIVE™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocular Technology Group - international" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ocular Technology Group - international". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ocular Technology Group - international, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ocular Technology Group - international, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".